Company logo

OMER - Omeros Corporation

NASDAQ -> Healthcare -> Biotechnology
Seattle, United States

OMER price evolution
OMER
(in millions $) 31 Mar 2022 31 Dec 2021 30 Sep 2021 30 Jun 2021
Current assets
Cash $8.96 $100.81 $7.42 $12.7
Short term investments $133.27 $56.46 $42.96 $60.96
Net receivables $16.25 $38.16 $33.9 $31.84
Inventory $0.71 $0.98
Total current assets $210.22 $247.89 $91.35 $112.4
Long term investments $1.05 $1.05 $1.05 $1.05
Property, plant & equipment $24.36 $30.01 $30.87 $31.73
Goodwill & intangible assets
Total noncurrent assets $159.04 $171.38 $32.08 $32.99
Total investments $134.32 $57.51 $44.01 $62.01
Total assets $369.26 $419.27 $123.43 $145.39
Current liabilities
Accounts payable $7.34 $13.4 $10.03 $9.5
Deferred revenue
Short long term debt $3.92 $5.25 $5.09 $4.87
Total current liabilities $35.07 $51.79 $42.82 $47.7
Long term debt $338.2 $342.58 $343.31 $343.99
Total noncurrent liabilities $339.12 $343.7 $343.31 $343.99
Total debt $342.13 $347.84 $348.4 $348.86
Total liabilities $374.19 $395.49 $386.13 $391.69
Shareholders' equity
Retained earnings -$716.14 -$683.13 -$963.75 -$941.05
Other shareholder equity -$941.05
Total shareholder equity -$4.92 $23.78 -$262.7 -$246.3
(in millions $) 31 Dec 2021 31 Dec 2020 31 Dec 2019 31 Dec 2018
Current assets
Cash $100.81 $10.5 $3.08 $5.86
Short term investments $56.46 $124.45 $57.7 $54.64
Net receivables $38.16 $3.84 $35.19 $22.82
Inventory $1.35 $1.15 $0.09
Total current assets $247.89 $151.28 $103.75 $89.87
Long term investments $1.05 $1.05 $1.15 $1.15
Property, plant & equipment $30.01 $28.08 $30.91 $3.85
Goodwill & intangible assets
Total noncurrent assets $171.38 $29.76 $33.22 $6.07
Total investments $57.51 $125.51 $58.86 $55.79
Total assets $419.27 $181.04 $136.97 $95.94
Current liabilities
Accounts payable $13.4 $4.2 $5.33 $6.28
Deferred revenue
Short long term debt $5.25 $3.78 $3.5 $0.89
Total current liabilities $51.79 $36.74 $55.46 $37.36
Long term debt $342.58 $265.06 $190.53 $150.56
Total noncurrent liabilities $343.7 $265.06 $190.53 $158.74
Total debt $347.84 $268.84 $194.03 $151.45
Total liabilities $395.49 $301.79 $245.99 $196.09
Shareholders' equity
Retained earnings -$683.13 -$872.67 -$734.61 -$650.13
Other shareholder equity
Total shareholder equity $23.78 -$120.75 -$109.02 -$100.16
(in millions $) 31 Mar 2022 31 Dec 2021 30 Sep 2021 30 Jun 2021
Revenue
Total revenue -$79.89 $30 $28.82
Cost of revenue -$0.94 $0.33 $0.34
Gross Profit -$78.95 $29.67 $28.48
Operating activities
Research & development $24.09 $27.42 $27.06 $30.94
Selling, general & administrative $10.96 -$5.63 $20.86 $21.56
Total operating expenses $35.05 $21.79 $47.92 $52.5
Operating income -$35.05 -$100.74 -$18.25 -$24.02
Income from continuing operations
EBIT -$28.07 $285.57 -$17.79 -$23.68
Income tax expense
Interest expense $4.94 $4.95 $4.91 $4.91
Net income
Net income -$33.01 $280.62 -$22.7 -$28.59
Income (for common shares) -$33.01 $280.62 -$22.7 -$28.59
(in millions $) 31 Dec 2021 31 Dec 2020 31 Dec 2019 31 Dec 2018
Revenue
Total revenue $73.81 $111.81 $29.87
Cost of revenue $0.9 $0.86 $0.51
Gross Profit $72.91 $110.94 $29.36
Operating activities
Research & development $118.78 $110.82 $109.7 $89.86
Selling, general & administrative $54.84 $72.69 $64.63 $51.72
Total operating expenses $173.62 $183.51 $174.32 $141.58
Operating income -$173.62 -$110.6 -$63.38 -$112.22
Income from continuing operations
EBIT $213.9 -$123.32 -$61.83 -$123.43
Income tax expense -$12.01 -$12.93
Interest expense $19.67 $26.75 $22.66 $16.25
Net income
Net income $194.24 -$138.06 -$84.49 -$126.76
Income (for common shares) $194.24 -$138.06 -$84.49 -$126.76
(in millions $) 31 Mar 2022 31 Dec 2021 30 Sep 2021 30 Jun 2021
Net income -$33.01 $280.62 -$22.7 -$28.59
Operating activities
Depreciation $0.28 $0.32 $0.32 $0.35
Business acquisitions & disposals $125.99
Stock-based compensation $3.89 $5.55 $5.69 $3.12
Total cash flows from operations -$15.19 -$18.21 -$23.66 -$27.59
Investing activities
Capital expenditures -$0.07 -$0.1 -$0.09
Investments -$76.81 -$13.5 $18 $30.5
Total cash flows from investing -$76.81 $112.42 $17.9 $30.41
Financing activities
Dividends paid
Sale and purchase of stock $0.41 $0.31 $0.61 $1.14
Net borrowings -$0.25 -$1.12 -$0.13 -$0.28
Total cash flows from financing $0.16 -$0.81 $0.48 $0.85
Effect of exchange rate
Change in cash and equivalents -$91.84 $93.39 -$5.29 $3.67
(in millions $) 31 Dec 2021 31 Dec 2020 31 Dec 2019 31 Dec 2018
Net income $194.24 -$138.06 -$84.49 -$126.76
Operating activities
Depreciation $1.39 $1.62 $1.79 $0.96
Business acquisitions & disposals $125.99
Stock-based compensation $17.63 $14.93 $13.79 $11.71
Total cash flows from operations -$109.72 -$100.09 -$60.07 -$103.74
Investing activities
Capital expenditures -$0.28 -$0.28 -$0.33 -$0.57
Investments $67.99 -$66.75 -$3.07 $25.72
Total cash flows from investing $193.71 -$67.03 -$3.4 $25.15
Financing activities
Dividends paid
Sale and purchase of stock $8.38 $98.7 $61.84 $6.73
Net borrowings -$1.82 $68.19 -$1.14 $102.82
Total cash flows from financing $6.32 $174.53 $60.7 $81.05
Effect of exchange rate
Change in cash and equivalents $90.31 $7.42 -$2.78 $2.47
Fundamentals
Market cap $291.07M
Enterprise value $624.23M
Shares outstanding 62.73M
Revenue -$21.06M
EBITDA $217.30M
EBIT $216.03M
Net Income $196.31M
Revenue Q/Q -100.00%
Revenue Y/Y -129.52%
P/E ratio 1.48
EV/Sales -29.64
EV/EBITDA 2.87
EV/EBIT 2.89
P/S ratio -13.82
P/B ratio -59.10
Book/Share -0.08
Cash/Share 0.14
EPS $3.13
ROA 74.27%
ROE -160.21%
Debt/Equity 16.63
Net debt/EBITDA 1.68
Current ratio 6.00
Quick ratio 6.00